| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910996 | Lung Cancer | 2014 | 7 Pages |
Abstract
Our results suggest that AMPK activation status affects response to erlotinib in distinct lung tumor models.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Helen J. Hülsmann, Jana Rolff, Christian Bender, Mostafa Jarahian, Ulrike Korf, Ralf Herwig, Holger Fröhlich, Michael Thomas, Johannes Merk, Iduna Fichtner, Holger Sültmann, Ruprecht Kuner,